Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.30
+0.33 (5.53%)
Sep 16, 2025, 11:04 AM EDT - Market open
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $391.36 million as of September 16, 2025. Its market cap has increased by 2.06% in one year.
Market Cap
391.36M
Enterprise Value
211.66M
1-Year Change
2.06%
Ranking
Category
Stock Price
$6.30
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $391.36M, a decrease of -1.60%. That is a compound annual growth rate of -0.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 370.86M | -9.68% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |